P183 Once-daily versus twice-daily mesalazine for active ulcerative colitis: Efficacy results from MOTUS, a multicentre, controlled, randomised, investigator-blinded study.

Details

Language :

English

ISSN :

18739946

Volume :

6

Database :

Supplemental Index

Journal :

Journal of Crohn's & Colitis

Publication Type :

Academic Journal

Accession number :

71512958

Full Text :

https://doi.org/10.1016/S1873-9946(12)60203-7